Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin

被引:0
|
作者
Carroll B. Leevy
机构
[1] University of Medicine & Dentistry of New Jersey,Department of Medicine, Division of Gastroenterology/Hepatology
[2] New Jersey Medical School Liver Center,undefined
关键词
D O I
10.1007/s10620-008-0252-8
中图分类号
学科分类号
摘要
引用
收藏
页码:2009 / 2009
相关论文
共 50 条
  • [11] Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy
    Poynard, Thierry
    Colombo, Massimo
    Bruix, Jordi
    Schiff, Eugene
    Terg, Ruben
    Flamm, Steven
    Moreno-Otero, Ricardo
    Carrilho, Flair
    Schmidt, Warren
    Berg, Thomas
    McGarrity, Thomas
    Heathcote, E. Jenny
    Goncales, Fernando
    Diago, Moises
    Craxi, Antonio
    Silva, Marcelo
    Bedossa, Pierre
    Mukhopadhyay, Pabak
    Griffel, Louis
    Burroughs, Margaret
    Brass, Clifford
    Albrecht, Janice
    GASTROENTEROLOGY, 2009, 136 (05) : 1618 - 1628
  • [12] Pegylated interferon alfa 2b (PEG-IFN) and ribavirin for hepatitis C patients who were nonresponders to previous therapy
    Lawitz, EJ
    Cantu, NS
    Becker, S
    Dhar, R
    Li, J
    Bala, NS
    Gordon, S
    Davis, M
    Nader, P
    Holtzmuller, K
    Rosenfield, T
    Monsour, H
    GASTROENTEROLOGY, 2002, 122 (04) : A626 - A626
  • [13] Interferon alfa-2b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapy
    Lo Iacono, O
    Castro, A
    Diago, M
    Moreno, JA
    Fernandez-Bermejo, M
    Vega, P
    García, V
    Carbonell, P
    Sanz, P
    Borque, MJ
    García-Buey, L
    García-Monzón, C
    Pedreira, J
    Moreno-Otero, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (04) : 463 - 469
  • [14] Pegylated interferon alfa-2b plus ribavirin in the retreatment of interferon-ribavirin nonresponder patients
    Taliani, G
    Gemignani, G
    Ferrari, C
    Aceti, A
    Bartolozzi, D
    Blanc, PL
    Capanni, M
    Esperti, F
    Forte, P
    Guadagnino, V
    Mari, T
    Marino, N
    Milani, S
    Pasquazzi, C
    Rosina, F
    Tacconi, D
    Toti, M
    Zignego, AL
    Messerini, L
    Stroffolini, T
    GASTROENTEROLOGY, 2006, 130 (04) : 1098 - 1106
  • [15] Chronic hepatitis C: Retreatment of pegylated interferon/ribavirin nonresponders
    Cardoso, Helder
    Vale, Ana Horta
    Mendes, Margarida
    Bastos, Pedro
    Machado, Artur
    Santos, Carlos
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S192 - S193
  • [16] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    Current Gastroenterology Reports, 2006, 8 (1) : 46 - 52
  • [17] Interferon alfa-2b and ribavirin in patients with resistant chronic hepatitis C.
    Min, AD
    Jones, JL
    Jacobson, IM
    Klion, FM
    Goldman, IS
    Esposito, S
    Geders, JM
    Tobias, H
    Bodenheimer, HC
    HEPATOLOGY, 1999, 30 (04) : 192A - 192A
  • [18] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    Current Hepatitis Reports, 2006, 5 (3) : 114 - 120
  • [19] A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C
    Glue, P
    Rouzier-Panis, R
    Raffanel, C
    Sabo, R
    Gupta, SK
    Salfi, M
    Jacobs, S
    Clement, RP
    HEPATOLOGY, 2000, 32 (03) : 647 - 653
  • [20] Virologic response to treatment with Pegylated Interferon alfa-2b and Ribavirin for chronic hepatitis C in children
    Pawlowska, Malgorzata
    Pilarczyk, Malgorzata
    Halota, Waldemar
    MEDICAL SCIENCE MONITOR, 2010, 16 (12): : CR616 - CR621